Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2002
10/03/2002US20020141966 Compositions for treatment of malignant effusions, and methods of making and using the same
10/03/2002US20020141965 Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents
10/03/2002US20020141947 Biocompatible particles having therapeutic, prophylactic or diagnostic agent, and of given mass mean diameter and aerodynamic diameter; at least 46% of the mass of particles are deposited after the first bifurcation of the lungs
10/03/2002US20020141946 Formulation of dipalmitoylphosphatidyl choline (DPPC), insulin and sodium citrate
10/03/2002US20020141945 Characteristic glass transition temperature (Tg) and a recommended storage temperature (Ts), glassy matrix and drug within the glassy matrix; unit dosage; stable dispersion over time
10/03/2002US20020141944 Stable pharmaceutical budersonide preparation for producing propellant-free aerosols
10/03/2002US20020141943 Iron-containing nanoparticles with double coating and their use in diagnosis and therapy
10/03/2002US20020140137 Inorganic shaped bodies and methods for their production and use
10/03/2002US20020140118 Focused acoustic energy used to eject droplet of solution which is directed into or through antisolvent that upon admixture with solution droplet causes compound in drop to precipitate; antisolvent is supercritical fluid
10/03/2002CA2692295A1 Combined use of methylol-transfer agents and fas-ligands in the treatment of cancer
10/03/2002CA2445125A1 Microemulsions as precursors to solid nanoparticles
10/03/2002CA2442280A1 A stable pharmaceutical composition of pravastatin
10/03/2002CA2442273A1 Carbon nanotubes in structures and repair compositions
10/03/2002CA2442261A1 Liposome composition for improved intracellular delivery of a therapeutic agent
10/03/2002CA2442080A1 A preparation for restenosis prevention
10/03/2002CA2441940A1 Dental formulation
10/03/2002CA2441824A1 Use of lipoaminoacids as absorption promoters in a pharmaceutical composition
10/03/2002CA2441809A1 Lipsomal vaccines comprising dilipopetides for modulating t1 and t2 immune responses
10/03/2002CA2441228A1 Combination treatment of pancreatic cancer
10/03/2002CA2441227A1 Liposome targeting of matrix metalloproteinase inhibitors
10/03/2002CA2440713A1 Nicotine-containing oral dosage form
10/03/2002CA2440387A1 Delivery of drugs from sustained release devices implanted in myocardial tissue or in the pericardial space
10/03/2002CA2440040A1 One-step process for preparing chewing gum
10/03/2002CA2437287A1 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity
10/03/2002CA2429181A1 Medicated tattoos
10/03/2002CA2410469A1 Improved forms of pharmaceutically active agents and method for manufacture thereof
10/02/2002EP1245649A2 Low foam N-alkyltartarimide and N-alkylmalimide wetting agents
10/02/2002EP1245636A1 Composition for hydrogel, hydrogel, and use thereof
10/02/2002EP1245580A1 Fibre containing composition for enteral nutrition
10/02/2002EP1245577A1 Process for cooking/drying of amylose rich starches
10/02/2002EP1245276A2 Improved solid media
10/02/2002EP1245249A2 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug
10/02/2002EP1245233A1 System for stabilizing lacrimal fluid layer
10/02/2002EP1245232A1 Oral solid preparation
10/02/2002EP1245231A2 Pharmaceutical formulations containing darifenacin
10/02/2002EP1245229A2 Methods and compositions for inhibition of angiogenesis
10/02/2002EP1245227A1 A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
10/02/2002EP1245223A1 Cosmetic composition comprising a mixture of fibres
10/02/2002EP1244805A1 Viral core protein-cationic lipid-nucleic acid-delivery complexes
10/02/2002EP1244755A2 Pressure sensitive adhesive and biomedical electrodes using same
10/02/2002EP1244728A1 Microcrystalline cellulose cushioning granules
10/02/2002EP1244667A2 Cyclohexene nucleic acids
10/02/2002EP1244657A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin
10/02/2002EP1244630A1 Amphiphilic polyamines, the use and method for synthesis thereof
10/02/2002EP1244629A2 Quinolone compounds for use in treating viral infections
10/02/2002EP1244514A1 Method for collecting and encapsulating fine particles
10/02/2002EP1244487A1 Aerosol inhaler
10/02/2002EP1244485A1 Method and apparatus for locating the injection point of an implanted medical device
10/02/2002EP1244472A2 Particulate vitamin composition
10/02/2002EP1244471A1 Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof
10/02/2002EP1244468A2 Selective activation of a th1 or th2 lymphocyte regulated immune response
10/02/2002EP1244458A2 Weight promoting composition, method, and product
10/02/2002EP1244455A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency
10/02/2002EP1244449A1 Use of ketotifen as ophthalmic agent
10/02/2002EP1244444A1 Process for formulation of carbapenem antibiotic compositions
10/02/2002EP1244439A1 Oral glutamine in the prevention of neonatal necrotizing enterocolitis and other gastrointestinal mucosal damage
10/02/2002EP1244434A2 Use of chemotherapeutic agents
10/02/2002EP1244432A2 Methods for pulmonary delivery of interleukin-2
10/02/2002EP1244431A1 Transdermal administration of reboxetine
10/02/2002EP1244430A2 Coating system
10/02/2002EP1244429A1 Controlled release kci tablet formulations
10/02/2002EP1244428A1 Pharmaceutical superdisintegrant
10/02/2002EP1244427A2 Pharmaceutical compositions for oral administration
10/02/2002EP1244426A1 Methods and formulations for the efficient delivery of water-insoluble drugs by nebulizer
10/02/2002EP1244424A2 Personal care articles comprising a hydrophilic conditioning agent exhibiting a defined leaching value
10/02/2002EP1244418A2 Oil-in-water type cosmetic or dermatological preparations
10/02/2002EP1244401A1 Drug delivery of phase changing formulation
10/02/2002EP1244388A2 Intervertebral disc treatment devices and methods
10/02/2002EP1144459B1 Cross-linked hyaluronic acids and medical uses thereof
10/02/2002EP1139762B1 Hydrogen peroxide disinfectant with increased activity
10/02/2002EP1123103B1 A process for producing an iron-dextran compound
10/02/2002EP1100803B1 Pyrrolo [2,1-b] [1,3]benzothiazepines with atypical antipsychotic activity
10/02/2002EP1079814B1 Electrostatic layering process and coated units obtained thereby
10/02/2002EP1071481B1 Preparation for regenerating collagen
10/02/2002EP1061961A4 Apparatuses and processes for whole-body hyperthermia
10/02/2002EP1032372B1 Masking agent in powder form for pharmaceutical flavours
10/02/2002EP0989851B1 Self-emulsifying formulation for acidic lipophilic compounds
10/02/2002EP0928187A4 Antibacterial composition
10/02/2002EP0841946B1 Methods for treatment of allergic asthma
10/02/2002EP0744937B1 Inoculation of animals with dried, pelleted biological materials
10/02/2002DE10115740A1 Zubereitung für die Restenoseprophylaxe Preparation for the prophylaxis of restenosis
10/02/2002DE10114509A1 Production of encapsulated product fixed to surface, by applying mixture of film-forming polymer, core material (especially fragrance or aroma) and organic solvent to surface and drying
10/02/2002DE10114364A1 Verfahren zur Herstellung von antibiotischen Kompositen A process for producing antibiotic composites
10/02/2002DE10114245A1 Herstellung und Verwendung einer Antibiotikum-/Antibiotika-Zubereitung Preparation and Use of an antibiotic / antibiotics preparation
10/02/2002DE10114244A1 Antibiotikum-/Antibiotika-Zubereitung mit retardierender Wirkstofffreisetzung Antibiotic / antibiotics preparation with retarding active ingredient release
10/02/2002DE10113284A1 Adjuvans-Emulsion und Verfahren zu deren Verwendung Adjuvant emulsion, and methods of use thereof
10/02/2002DE10112325A1 Lagerstabile Fertiginfusionslösungen des Paracetamols Storage stable finished infusion solutions of paracetamol
10/02/2002DE10111780A1 Effervescent tablet, useful for medical, cosmetic, cleaning or drink preparation purposes, comprises a cover layer provided on opposite sides with openings
10/02/2002DE10111767A1 Verfahren zur Herstellung von Polyestern aus Hydroxycarbonsäuren und Polyolen durch Polykondensation A process for the preparation of polyesters of hydroxycarboxylic acids and polyols by polycondensation
10/02/2002DE10108123A1 Wirkstoffkombination Combination of active ingredients
10/02/2002DE10108122A1 Arzneimittel auf Basis von Tramadol Medicines based on tramadol
10/02/2002CN1372472A Pernasally absorbable insulin preparations
10/02/2002CN1372468A Oral preparations of etidronate disodium
10/02/2002CN1372467A Improved topical medicaments and methods for photodynamic treatment of disease
10/02/2002CN1372466A New use of docetaxel for treating hepatoma
10/02/2002CN1372463A Patches for external use
10/02/2002CN1372462A Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system
10/02/2002CN1372461A Aqueous carrier systems for water-insoluble aromatic polymers
10/02/2002CN1372450A Enhanced wound converage to enhance wound healing
10/02/2002CN1371748A Zhonghua soft-shelled turtle aeromonad oral slow-releasing microsphere vaccinum and preparation process thereof
1 ... 2228 2229 2230 2231 2232 2233 2234 2235 2236 2237 2238 2239 2240 2241 2242 2243 2244 2245 2246 2247 2248 ... 2991